Neurocognitive Disorder Treatment Market Forecast Opportunity Analysis-2027

1. NEUROCOGNITIVE DISORDER TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Neurocognitive Disorder Treatment Market - Overview Global NeurocognitiveDisorder Treatment Market: Market Dynamics Increasing prevalence of neurocognitive disorder is expected to augment the global Neurocognitive Disorder Treatment Market growth. Due to advancement in technology and inventions such as Al and adoption of unhealthy work practices, increased cardiovascular issues are boosting the global neurocognitive disorder market. Moreover, increased addiction of drugs and alcohol in youth and also changing climate conditions or respiratory diseases are causing neurocognitive disorders and driving the market growth. Furthermore, increase in number of geriatric population is also the factor affecting the market growth. Approvals of the drugs associated with the treatment from the regulatory bodies is the factor that drives the market growth. For instance, on April 11, 2019, the U.S.FDA accepted the resubmitted new drug application (NDA) for instradefylline (KW-6002), which is an oral selective adenosine receptor antagonist for use as adjunctive treatment for Parkinson’s disease in adults. On May 20, 2019, the U.S.FDA approved Neuronascent Investigational New Drug (IND) application for NNI-362. For instance, on March 21, 2019, Biogen and Eisei, Co., Ltd announced the decision to discontinue the global phase 3 trial of Aducanumab, which is designed to evaluate the safety and efficacy of an antibody-aducanumab in patients with Alzheimer disease. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/neurocognitive-disorder-treatment-market-2676 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Neurocognitive disorders include dementia, delirium, and mild cognitive impairment, which is characterized by decline of the level of cognitive functioning. Neurocognitive deficit is a reduction or impairment of cognitive functions and affects nerve cells and often impact the person’s ability to remember, to reason, and to make judgments. The neurocognitive disorders have different clinical characteristics with Alzheimer disease, front temporal degeneration, cerebrovascular disease, traumatic brain injury, Lewy body disease, and infections showing the common causes. Alzheimer disease is the most common cause of neurocognitive disorder. In the early stages of Alzheimer, people are not able to remember the recent events, conversations, and names of people and may also experience the depression. Individuals with neurocognitive disorder show the side effects like mood disturbances including apathy, depression, anxiety and sleep disturbance including insomnia, hypersomnia. Neurocognitive disorder treatments include pain medications, surgeries, physical therapy, bed rest, and others. Furthermore, for treatment of neurocognitive disorder, antibiotics are used to clear the remaining infections, which is affecting the brain, such as meningitis. North America is expected to hold a dominant position in the global neurocognitive disorder treatment market, owing to adoption of advanced technology and rising number of neurocognitive disorder patients. According to the World Health Organization (WHO), nearly 35.6 million people live with dementia worldwide. The number of geriatric population worldwide and related dementia patients is expected to rise up to 65.7 million in 2030 and 115.4million in 2050. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2676 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Global Neurocognitive Disorder Treatment Market: Competitive Landscape The key players in global neurocognitive disorder treatment market are focusing on developing innovative, new, and efficient neurocognitive disorder treatment drugs that are launched in the market to meet the demand from consumers for various types of neurocognitive disorder treatments. For instance, in March 2018, Biogen announced to enter into an agreement to acquire Pfizer Inc. phase 2b ready AMPA receptor potentiator for cognitive impairment. Furthermore, in May 2019, T3D therapeutics received grant of US$ 9 million from National Institute on Aging (NIA) to develop drug T3D-959 for neurocognitive disease. Key players operating in the global neurocognitive disorder treatment market include A B Science, Abbive, A C immune, Biogen, Eisai, Immunobrain, Mediti Pharma Inc., Ono Pharmaceuticals, Proclar Biosciences, Problodrug AG, Roche, T3D Therapeutics, and Purdue Pharma. Furthermore, according WHO, the prevalence of dementia is increasing exponentially with age and sex in North America region, doubling in every 5.5 years. Moreover, satisfactory reimbursement policies, rising adoption of advance precautious methods and increasing penetration of life science analytics for monitoring health changes continuously are factors driving the growth of market in North America. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2676 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved